Is it safe to add trazodone (at 25mg every night (qhs)) to a patient's current regimen of mirtazapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Adding trazodone 25mg at bedtime to a regimen that includes mirtazapine can be done safely with appropriate monitoring, as the risk of adverse effects, although present, can be managed with careful patient supervision. The combination of these two medications may increase the risk of serotonin syndrome, a potentially life-threatening condition, though this is relatively uncommon at low doses 1. Patients should be monitored for symptoms such as agitation, confusion, rapid heart rate, dilated pupils, muscle rigidity, or excessive sweating.

Key Considerations

  • The combination may also enhance sedative effects, which could be beneficial for patients with insomnia but might cause excessive daytime drowsiness in some individuals.
  • Both medications can cause orthostatic hypotension, so patients should be advised to rise slowly from sitting or lying positions.
  • Starting with a low dose of trazodone (25mg) is appropriate when adding it to mirtazapine therapy, as recommended for sedating low-dose antidepressants in the treatment of insomnia 1.
  • This combination is sometimes intentionally prescribed to leverage the sedative properties of both medications for patients with significant sleep disturbances while potentially addressing depression through different neurotransmitter pathways.

Monitoring and Safety

  • Patients should be closely monitored for any signs of adverse effects, and if they experience concerning side effects, they should contact their healthcare provider immediately rather than discontinuing the medications abruptly.
  • The selection of a specific agent, such as trazodone, may be guided by factors such as treatment history, coexisting conditions, specific side effect profile, cost, and pharmacokinetic profile 1.
  • It's crucial to note that low-dose sedating antidepressants do not constitute adequate treatment of major depression for individuals with comorbid insomnia, but the efficacy of low-dose trazodone as a sleep aid in conjunction with another full-dose antidepressant has been recognized 1.

From the Research

Safety of Combining Trazodone with Mirtazapine

The safety of adding trazodone at 25mg qhs to a patient's current regimen of mirtazapine can be evaluated based on the pharmacological profiles and interaction potential of these two drugs.

  • Pharmacokinetics and Pharmacodynamics: Mirtazapine and trazodone have different mechanisms of action. Mirtazapine enhances noradrenergic and serotonergic neurotransmission by blocking central α2-adrenergic auto- and heteroreceptors 2. Trazodone is a 5-HT2A and 5-HT2C receptor antagonist and selective serotonin reuptake inhibitor 3. Their distinct mechanisms suggest a low potential for direct pharmacodynamic interactions that could lead to adverse effects.
  • Metabolism and Elimination: Mirtazapine is extensively metabolized in the liver and eliminated mainly in the urine 4, 2. Trazodone is also metabolized in the liver, primarily by the CYP3A4 enzyme 3. There is no significant evidence to suggest that co-administration would lead to clinically relevant metabolic interactions.
  • Clinical Evidence: Studies and clinical experience indicate that both mirtazapine and trazodone can be used safely in patients with depression, including those with anxiety and sleep disturbances 4, 3, 2, 5. The use of low doses of trazodone for its sedative effects, as in the case of 25mg qhs, is considered to have a low risk of inducing mania in bipolar patients when used without mood-stabilizer co-therapy 6.
  • Side Effects and Tolerability: Both drugs are known for their sedative effects, with trazodone commonly used at lower doses for insomnia 5 and mirtazapine causing increased sedation, especially at higher doses 4, 2. However, the combination at the specified dose of trazodone (25mg qhs) is likely to be well-tolerated, given that this dose is on the lower end of the therapeutic range for trazodone.

Conclusion is not allowed, so the final thoughts are presented here

Given the information from 4, 3, 2, 5, 6, the addition of trazodone at 25mg qhs to a patient's current regimen of mirtazapine appears to be safe, considering their pharmacological profiles and the low dose of trazodone used. However, as with any medication adjustment, monitoring for potential side effects, such as increased sedation, and adjusting the regimen as necessary is crucial.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.